Weiying Zhang1, Tricia L Nilles1, Jacquett R Johnson1, Joseph B Margolick2. 1. Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 2. Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. jmargol1@jhu.edu.
Abstract
BACKGROUND: Both HIV infection and frailty have been associated with chronic immune activation. One possible explanation for this chronic immune activation could be low levels of CD4(+) T regulatory cells (Tregs), which suppress immune responses. METHODS: HIV-uninfected (HIV-) and HIV-infected (HIV+) men in the Multicenter AIDS Cohort Study (MACS) were classified as frail (or nonfrail) if they expressed (or did not express) the Fried frailty phenotype at two consecutive study visits. Percentages and absolute numbers of total Tregs, and percentages of different subsets of Tregs and of activated T cells were measured by flow cytometry. The function of Tregs was measured by suppression of T-cell proliferation. RESULTS: Percentages of Tregs were higher, rather than lower, in frail men than in nonfrail men, and this difference was significant for HIV- men. Percentages of subsets of Tregs did not differ significantly by frailty status. Among HIV+ men, the suppressive function of Tregs was similar between frail and nonfrail men. Percentages of Tregs and activated T cells were negatively correlated in nonfrail men (HIV- and HIV+) and in frail HIV- men, but this correlation was strongly positive in frail HIV+ men. CONCLUSION: These data suggest that: (a) Tregs were not deficient in frail men; and (b) the immunological pathophysiology of frailty may differ by HIV status.
BACKGROUND: Both HIV infection and frailty have been associated with chronic immune activation. One possible explanation for this chronic immune activation could be low levels of CD4(+) T regulatory cells (Tregs), which suppress immune responses. METHODS:HIV-uninfected (HIV-) and HIV-infected (HIV+) men in the Multicenter AIDS Cohort Study (MACS) were classified as frail (or nonfrail) if they expressed (or did not express) the Fried frailty phenotype at two consecutive study visits. Percentages and absolute numbers of total Tregs, and percentages of different subsets of Tregs and of activated T cells were measured by flow cytometry. The function of Tregs was measured by suppression of T-cell proliferation. RESULTS: Percentages of Tregs were higher, rather than lower, in frail men than in nonfrail men, and this difference was significant for HIV- men. Percentages of subsets of Tregs did not differ significantly by frailty status. Among HIV+ men, the suppressive function of Tregs was similar between frail and nonfrail men. Percentages of Tregs and activated T cells were negatively correlated in nonfrail men (HIV- and HIV+) and in frail HIV- men, but this correlation was strongly positive in frail HIV+ men. CONCLUSION: These data suggest that: (a) Tregs were not deficient in frail men; and (b) the immunological pathophysiology of frailty may differ by HIV status.
Authors: R Detels; L Jacobson; J Margolick; O Martinez-Maza; A Muñoz; J Phair; C Rinaldo; S Wolinsky Journal: Public Health Date: 2011-12-27 Impact factor: 2.427
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Michael M Lederman; Nicholas T Funderburg; Rafick P Sekaly; Nichole R Klatt; Peter W Hunt Journal: Adv Immunol Date: 2013 Impact factor: 3.543
Authors: Nana-Maria Wagner; Gunnar Brandhorst; Frauke Czepluch; Mareike Lankeit; Christoph Eberle; Sebastian Herzberg; Vivien Faustin; Joachim Riggert; Michael Oellerich; Gerd Hasenfuss; Stavros Konstantinides; Katrin Schäfer Journal: Obesity (Silver Spring) Date: 2013-03 Impact factor: 5.002
Authors: Maria E Moreno-Fernandez; Wildeman Zapata; Jason T Blackard; Genoveffa Franchini; Claire A Chougnet Journal: J Virol Date: 2009-10-14 Impact factor: 5.103
Authors: Joseph B Margolick; Jay H Bream; Otoniel Martínez-Maza; Joe Lopez; Xiuhong Li; John P Phair; Susan L Koletar; Lisa P Jacobson Journal: J Acquir Immune Defic Syndr Date: 2017-04-01 Impact factor: 3.731
Authors: Amy C Justice; Kristine M Erlandson; Peter W Hunt; Alan Landay; Paolo Miotti; Russell P Tracy Journal: J Infect Dis Date: 2018-01-30 Impact factor: 5.226
Authors: Alyssa Vecchio; Gertrude Nakigozi; Noeline Nakasujja; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Kevin Robertson; Maria J Wawer; Ned Sacktor; Leah H Rubin; Deanna Saylor Journal: J Neurovirol Date: 2021-03-31 Impact factor: 2.643
Authors: Thomas D Brothers; Susan Kirkland; Olga Theou; Stefano Zona; Andrea Malagoli; Lindsay M K Wallace; Chiara Stentarelli; Cristina Mussini; Julian Falutz; Giovanni Guaraldi; Kenneth Rockwood Journal: PLoS One Date: 2017-10-05 Impact factor: 3.240